Michael Gelband’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-626,596
Closed -$1.59M 1634
2026
Q1
$1.59M Buy
+626,596
New +$1.6M 0.01% 859
2025
Q3
Sell
-54,309
Closed -$234K 1591
2025
Q2
$234K Sell
54,309
-289,362
-84% -$1.17M ﹤0.01% 1284
2025
Q1
$1.35M Buy
+343,671
New +$1.63M 0.01% 832
2023
Q3
Sell
-429,256
Closed -$4.09M 1755
2023
Q2
$4.09M Buy
429,256
+224,477
+110% +$1.9M 0.03% 527
2023
Q1
$1.92M Sell
204,779
-151,146
-42% -$1.56M 0.02% 892
2022
Q4
$2.97M Buy
355,925
+156,020
+78% +$1.46M 0.04% 504
2022
Q3
$1.88M Buy
199,905
+155,349
+349% +$1.97M 0.02% 825
2022
Q2
$618K Buy
44,556
+12,511
+39% +$187K 0.01% 1276
2022
Q1
$537K Buy
+32,045
New +$531K 0.01% 1479
2021
Q4
Sell
-17,192
Closed -$377K 2207
2021
Q3
$377K Sell
17,192
-81,186
-83% -$1.97M 0.01% 1527
2021
Q2
$2.71M Buy
98,378
+24,318
+33% +$668K 0.03% 548
2021
Q1
$1.95M Sell
74,060
-213,608
-74% -$5.84M 0.03% 576
2020
Q4
$8.55M Buy
287,668
+103,813
+56% +$3.07M 0.08% 150
2020
Q3
$5.7M Buy
183,855
+16,390
+10% +$444K 0.11% 156
2020
Q2
$3.74M Buy
167,465
+104,486
+166% +$2.36M 0.1% 223
2020
Q1
$1.31M Buy
+62,979
New +$1.26M 0.07% 251

Other funds holding CLVT

Michael Gelband's CLVT Position: Q2 2026 in Review

Michael Gelband sold out of Clarivate (CLVT) in Q2 2026, closing a stake of 626,596 shares — an estimated $1.59M sold.

Michael Gelband first reported a position in CLVT in Q1 2020 and held it in 16 quarters. The position peaked at $8.55M in Q4 2020. 239 funds tracked by Wall St. Rank hold CLVT as of Q2 2026.

  • Michael Gelband reported no remaining Clarivate position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 626,596 Clarivate shares in Q2 2026, an estimated $1.59M.
  • Michael Gelband first reported a position in Clarivate in Q1 2020 and held it in 16 quarters.
  • Michael Gelband's Clarivate position peaked at $8.55M in Q4 2020.
  • 239 funds tracked by Wall St. Rank held Clarivate as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.